SD

Suneeta Dubey

Active Director Director DIN 10213091
DIN 10213091 First appointment Jun 2023 Primary industry Education & Learing
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Suneeta Dubey

Data last updated:

Suneeta Dubey is a Director at Chaperon Biotech Private Limited (since 2023). The company operates in Education & Learing. Chaperon Biotech Private Limited reported revenue of ₹53 Lakh (FY 2024).

DIN 10213091
Primary Designation Director
Industry Education & Learing
First Appointment 27 Jun 2023
Oldest Company Age 13 yrs
Largest company Chaperon Biotech Private Limited · ₹53 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chaperon Biotech Private Limited U24233UP2013PTC056258
Director27 Jun 20232013₹53 Lakh (FY 2024)Active

Board colleagues of Suneeta Dubey

Directorship timeline

Open interactive timeline →
Chaperon Biotech Private Limited
Premium access

Shareholding and investment profile for Suneeta Dubey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suneeta Dubey

Suneeta Dubey currently holds 1 directorship: Chaperon Biotech Private Limited (Director, since 27 Jun 2023, revenue ₹53 Lakh (FY 2024)).

Suneeta Dubey was first appointed on 27 Jun 2023 as Director at Chaperon Biotech Private Limited.

The current boards of Suneeta Dubey's companies include Gyaneshwar Patel (Chaperon Biotech Private Limited), Saurabh Singh (Chaperon Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available